JD Health International Inc. (6618.HK) stock analysis

In our weekly check, JD Health International Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 5, red flags: 1.

About JD Health International Inc.

JD Health International Inc. is a Healthcare company (Medical - Pharmaceuticals) based in China, listed on HKSE as 6618.HK.

What our checks show for 6618.HK

Red flags

• The stock has fallen as much as 90% from a peak. Would you have held through that?

Warning signs

• Analysts expect the net margin to shrink by 0.3 points from today's 7.3%.
• The net margin is only 7.3%: little room if costs rise.
• The price swings a lot: 42.2% annual volatility. Expect large ups and downs.
• The stock is still below its previous peak.
• Return on capital (ROCE) is only 7.7%.

Strengths

• Debt is low: 0.01x equity.
• Operating profit covers interest 51.4 times over.
• The net margin rose by 10.8 points over 5 years, to 7.3%.
• The gross margin is 24.8% and has risen by 1.3 points: pricing power is holding.
• Operating cash flow is 1.85x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 17.5% a year over the next years.

Similar companies

SOBI.ST · 1177.HK · RADL3.SA · RPRX

Questions

What grade does JD Health International Inc. (6618.HK) have?

In our weekly check, JD Health International Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 18 pass, warnings: 5, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 6618.HK stock?

This week's biggest flags for JD Health International Inc.: Deep past fall, Margins expected to shrink, Thin margins. In total 6 of 24 checks show a warning or a red flag.

What does JD Health International Inc. do?

JD Health International Inc. is a Healthcare company (Medical - Pharmaceuticals) based in China, listed on HKSE as 6618.HK.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis